NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday:
Illumina Inc., down $19.12 to $208.33.
The genetic testing tools company reported disappointing second-quarter financial results.
Chevron Corp., up 23 cents to $159.85.
Energy companies lagged the broader market as crude oil prices fell.
Freeport-McMoRan Inc., down 5 cents to $31.62.
The copper mining company fell along with prices for the base metal.
ResMed Inc., down 86 cents to $239.99.
The maker of medical products for respiratory disorders warned investors about continued supply chain problems.
Broadridge Financial Solutions Inc., up $13.49 to $183.22.
The technology outsourcing company beat Wall Street's fiscal fourth-quarter financial results.
Johnson & Johnson, down $1.84 to $165.30.
The Band-Aid maker will stop selling baby powder containing talc next year amid lawsuits claiming it caused cancer.
Humana Inc., up $12.81 to $496.88.
The health insurer is buying most of the assets of Inclusa, a provider of long-term care services for older adults in Wisconsin.
Newmont Corp., up $1.25 to $46.55.
The gold producer rose as prices for the precious metal edged higher.
Before you consider Johnson & Johnson, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson & Johnson wasn't on the list.
While Johnson & Johnson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
